GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Net Income (Continuing Operations)

MicroTech Medical (Hangzhou) Co (HKSE:02235) Net Income (Continuing Operations) : HK$-67.7 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. MicroTech Medical (Hangzhou) Co's Net Income (Continuing Operations) for the six months ended in Dec. 2024 was HK$-27.1 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-67.7 Mil.

MicroTech Medical (Hangzhou) Co Net Income (Continuing Operations) Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co Net Income (Continuing Operations) Chart

MicroTech Medical (Hangzhou) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income (Continuing Operations)
Get a 7-Day Free Trial -143.73 -58.96 -39.13 -136.74 -67.39

MicroTech Medical (Hangzhou) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.26 -20.41 -116.33 -40.62 -27.10

MicroTech Medical (Hangzhou) Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-67.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroTech Medical (Hangzhou) Co  (HKSE:02235) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

MicroTech Medical (Hangzhou) Co Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » Net Income (Continuing Operations)
Comparable Companies
HKSE:06669 HKSE:09877 HKSE:01696 HKSE:02160 HKSE:09996 HKSE:01763 HKSE:06922 HKSE:02216 HKSE:02500 HKSE:06609 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN
Website
https://www.microtechmd.com
MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.
Executives
Orbimed Asia Partners V, L.p. 2101 Beneficial owner
Orbimed Asia Gp V, L.p. 2201 Interest of corporation controlled by you
Orbimed Advisors V Limited 2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Ii, L.p. 2201 Interest of corporation controlled by you
Qm32 Limited 2101 Beneficial owner
Qiming Venture Partners V, L.p. 2201 Interest of corporation controlled by you
Qiming Gp V, L.p. 2201 Interest of corporation controlled by you
Qiming Corporate Gp V, Ltd. 2201 Interest of corporation controlled by you
Lilly Asia Ventures Fund Gp, L.p. 2201 Interest of corporation controlled by you
Lav Evergreen (hong Kong) Co., Limited 2101 Beneficial owner
Lav Corporate Gp, Ltd. 2201 Interest of corporation controlled by you
Zheng Pan
Cd Capital Gp Ltd 2201 Interest of corporation controlled by you
Master Summer Limited 2201 Interest of corporation controlled by you
Cdbi Partners Gp, Ltd 2201 Interest of corporation controlled by you

MicroTech Medical (Hangzhou) Co Headlines

No Headlines